Sutro Biopharma, an immunotherapy developer commercialising technology created at Stanford University, has floated on the Nasdaq Global Market.

The home IoT platform floated at the foot of its range to raise almost $103m, while Xiaomi will retain a 16.4% stake in the company.

The Astra Zeneca antibiotic development spin off has floated in an initial public offering in which Novo bought more than $16m in shares.

The online survey platform, which counted Alphabet and Salesforce as investors, floated above its range while increasing the number of shares in the IPO.

Principia Biopharma, whose drug discovery platform is based on research at UCSF, has completed a $122m initial public offering after underwriters exercised their greenshoe option.

Karolinska Development has celebrated an exit as Umeå spinout Asarina Pharma went public in Sweden after raising $16.3m in its initial public offering.

The JD.com and Advance Publications-backed fashion e-commerce platform raised more than $670m while its investors sold $212m of shares.

Canopy Rivers, the corporate venturing unit spun out of cannabis grower Canopy Growth, has gone public through a reverse merger.

Zalando and Children’s Investment Fund Foundation have added $2.5m to Working Capital's supply chain-focused fund, which now stands at $25.2m.

The immuno-oncology therapy developer's investors include UC’s office of the chief investment officer, which contributed to a $300m round in January.